Allergan USA, Inc. et al v. Aurobindo Pharma Ltd. et al
| Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC |
| Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. |
| 1:2021cv01062 |
| July 23, 2021 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 30, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 16
SO ORDERED Granting (D.I. 15 in 21-cv-1062-RGA; D.I. 12 in 21-cv-1064-RGA; D.I. 12 in 21-cv-1061-RGA; D.I. 225 in 19-cv-1727-RGA; D.I. 11 in 21-cv-1065-RGA; D.I. 13 in 21-cv-1066-RGA; D.I. 12 in 21-cv-1063-RGA) Stipulation and Proposed Order to Consolidate and Extend Time (*Reset Deadlines/Hearings: Joint Claim Construction Brief due by 12/3/2021, Pretrial Order due by 10/11/2022, Status letter due by 7/6/2022, A Bench Trial is set to start 11/7/2022, at 8:30 AM in Courtroom 6A) (see Order for further details). Signed by Judge Richard G. Andrews on 8/30/2021. Associated Cases: 1:19-cv-01727-RGA et al.(nms)
|
| Filing 15 STIPULATION and [Proposed] Order to Consolidate and Extend Time, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: #1 Letter)(Tigan, Jeremy) Modified on 8/30/2021 (nms). |
| Filing 14 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,007,179 B2; 11,090,291 B2. (Tigan, Jeremy) Modified on 8/18/2021 (nms). |
| Filing 13 FIRST Amended Complaint against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. - filed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Eden Biodesign, LLC. (Attachments: #1 Exhibits A-B)(Tigan, Jeremy) Modified on 8/18/2021 (nms). |
| Filing 12 STIPULATION and [Proposed] Order by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) |
| Filing 11 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited, Inc. for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) Modified on 8/6/2021 (nms). |
| Filing 10 ANSWER to #1 Complaint, by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Filing 9 SUMMONS Returned Executed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Eden Biodesign, LLC. Aurobindo Pharma USA, Inc. served on 7/29/2021, answer due 8/19/2021. (Tigan, Jeremy) |
| Filing 8 SUMMONS Returned Executed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Eden Biodesign, LLC. Aurobindo Pharma Ltd. served on 7/29/2021, answer due 8/19/2021. (Tigan, Jeremy) |
| Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:21-cv-01061-RGA through 1:21-cv-01066-RGA (rjb) |
| Filing 7 Letter to John A. Cerino, Clerk of the Court from Jeremy A. Tigan regarding Notice of Related Cases. (Tigan, Jeremy) |
| Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:21-cv-01061-LPS through 1:21-cv-01066-LPS (rjb) |
| Filing 6 Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Ltd. on 7/26/2021; Aurobindo Pharma USA, Inc. on 7/26/2021. (Attachments: #1 Summons Issued)(mal) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.. (mal) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,007,179,B2. (mal) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: n/a. Date of Expiration of Patent: 03/14/2033. Thirty-Month Stay Deadline: n/a (mal) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Filing 1 COMPLAINT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3664621.) - filed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Eden Biodesign, LLC.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(mal) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
